WillItSurvive
Pharma and healthcare groups · United States

Cigna

cigna.com ↗

Cigna is a US health insurer running Evernorth, one of three giant PBMs.

Hard to displace
Assessed 24 July 2026 · Evidence as of 24 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 24 July 2026 · Checkable from July 30, 2026 · Every call on the record Checkpoint: Q2 2026 earnings, first full guidance under new CEO Brian Evanko plus eviCore divestiture update
The call

Cigna's size and licensing make it hard to replace; its risk sits in PBM margin reform and a lawsuit over its own use of automated claims denials, not in losing customers to a new AI rival.

Cigna makes money three ways: selling health insurance (which requires state-by-state government approval), managing prescription drugs through its pharmacy benefit manager (Express Scripts handles about 80% of US prescriptions), and using 185 million customer records to understand medical trends. It is hard for startups or AI models to copy because insurance requires expensive licenses in every state, pharmacy networks take years to build, and the customer data pile-up cannot be bought overnight. The real threat is not competition but new federal rules coming in 2027 that will force Cigna to split its rebate income with customers instead of keeping it, which will shrink profits at the pharmacy unit that funds much of the company's growth.

Why
01
Bigger players: UnitedHealth Group/Optum Rx, CVS Health/Aetna/Caremark. Both run their own vertically integrated insurer-PBM stacks at similar scale, competing head to head for the same employer and government contracts. Could a giant copy it? No, they are blocked.
02
What protects it. State insurance licensing, PBM scale (Express Scripts handles a huge share of US scripts), and 185M+ claims relationships that took decades to build.
What would change this call
Cigna's Q2 2026 earnings (July 30, 2026) guidance under new CEO Brian Evanko. Shows whether margin trajectory holds as rebate-delinking reform begins.
Evernorth operating margins during 2027-28 rebate-delinking transition. Indicates whether PBM profit engine compresses faster than guided.
Outcome/timing of eviCore divestiture and finalized ACA market exit. Shows whether Cigna is shrinking non-core lines or losing competitive ground.
Key numbers
  • FY2025 revenue $274.9B, up 11% year over year (2025-12-31)
  • 2026 outlook: ~$280B revenue guided (2026-02-04)
  • Evernorth specialty revenue $26.7B, up 14% in 2025 (2025-12-31)
Named risks
  • FTC-mandated rebate delinking could compress Evernorth margins faster than guided in 2027-28. Severity: high
  • Kisting-Leung v. Cigna algorithmic-denial class action pending as of May 2026 could reprice claims liability. Severity: medium
  • ACA exit and eviCore divestiture create portfolio and revenue uncertainty through 2027. Severity: medium
  • State regulators (e.g., California DMHC fine, Oct 2025) signal growing scrutiny of claims-denial practices. Severity: medium
  • Low AI-disclosure transparency ranking (44/100, D+, June 2026) could invite reputational and regulatory attention. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
UnitedHealth Group / Optum RxcontestingBoth among Big 3 PBMs controlling ~80% of US prescriptions as of 2026
CVS Health / Aetna / Caremarklosing toAetna exited ACA marketplace before Cigna's own exit announced May 29, 2026
CVS Health / CaremarkcontestingCaremark reached separate FTC settlement worth up to $8.5B savings, July 21, 2026
Humanacontesting2024 Cigna-Humana merger talks abandoned, per Nov 2024 reporting
Questions people ask
Is Cigna profitable in 2026?
Yes. Cigna reported Q1 2026 net income of $1.65 billion on $68.5 billion revenue, up from $1.3 billion a year earlier. Full-year 2026 guidance calls for adjusted operating income of at least $7.95 billion on roughly $280 billion revenue, per its February 4, 2026 outlook.
Who is Cigna's biggest competitor?
UnitedHealth Group (Optum Rx) and CVS Health (Aetna, Caremark) are Cigna's top rivals, together forming the 'Big 3' PBM oligopoly controlling about 80% of US prescriptions as of 2026. CVS's Aetna exited the ACA marketplace before Cigna announced its own exit in May 2026.
Is Cigna laying off employees in 2026?
Headcount fell to about 67,700 employees as of December 31, 2025, down 7.9% from 73,500 in 2024, driven by divestitures including the Medicare Advantage sale to HCSC and planned eviCore sale, per stockanalysis.com data published July 8, 2026.
Who owns Cigna?
Cigna is publicly traded on NYSE as CI with no controlling parent; Vanguard is its largest cited institutional shareholder with about 11.77 million shares as of July 17, 2026. Market capitalization was approximately $75.4 billion as of July 23, 2026.
Why is Cigna exiting the ACA marketplace?
Cigna announced on May 29, 2026 it will exit ACA individual marketplace exchanges after the 2026 plan year, affecting about 369,000 members across 11 states, following CVS's Aetna, which exited at the start of 2026, as insurers reassess exchange profitability.
Timeline
  • 2026-07-23Cigna expands AI-enabled care management, targets $200M savings over 3 years
  • 2026-07-01Brian Evanko becomes CEO, succeeding David Cordani; $100M AI pharmacy investment announced
  • 2026-05-29Cigna announces ACA marketplace exit affecting 369,000 members in 11 states
  • 2026-04-30Q1 2026 results: $68.5B revenue, $1.65B net income; eviCore sale pursued
  • 2026-03-03Cigna announces Evanko to succeed Cordani as CEO
  • 2026-02-04FTC settlement forces Express Scripts to delink PBM pay from rebates
  • 2026-02-04FY2025 results: $274.9B revenue (+11%), $6.0B net income; dividend raised
  • 2025-10-08California DMHC fines Cigna $500,000 for improper claims denials
Revision history
24 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Vertex PharmaceuticalsTenet HealthcareIntuitive Surgical
More in Pharma and healthcare groups →
Sources